Healthy Lung Study- Development of 3T MRI Hardware and Software for 3He Gas Imaging of the Lung: Healthy Volunteer Development Study
NCT03169673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2025-08-11
Summary
Healthy volunteers aged 18-75 will undergo hyperpolarized 3-Helium MRI and pulmonary function testing for the development of tools to assess image signal to noise and reproducibility of spin-density and diffusion-weighted imaging.
Conditions
- Healthy Volunteers
Interventions
- DIAGNOSTIC_TEST
-
Hyperpolarized Helium 3 Magnetic Resonance Imaging
Hyperpolarized noble gas imaging using Helium-3 has been used to explore structural and functional relationships in the lung in patients with lung disease and healthy controls. In contrast to proton-based MRI imaging, 3He gas is used as a contrast agent to directly visualize the airways, and thus ventilation. Whereas the normal density of gas is too low to produce an easily detectable signal, this is overcome by artificially increasing the amount of polarization per unit volume using optical pumping.
Sponsors & Collaborators
-
London Health Sciences Centre
collaborator OTHER -
Western University, Canada
lead OTHER
Principal Investigators
-
Grace E Parraga, PhD · Study Principal Investigator Robarts Research Institute, The University of Western Ontario
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-09-21
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging
NCT02279329 ·Status: RECRUITING ·Phase: NA
-
Imaging Measures of Respiratory Health Registry
NCT05102825 ·Status: RECRUITING
-
Study of Airflow in the Lungs Using Helium MRI
NCT02154568 ·Status: COMPLETED ·Phase: NA
-
Image and Model Based Analysis of Lung Disease
NCT03764163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
¹⁹F (Perfluoropropane) MRI
NCT07305532 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
129 Xenon MRI in Chronic Lung Disease
NCT02723500 ·Status: RECRUITING ·Phase: NA
-
Determinants of Respiratory Health in Young Adults
NCT00005361 ·Status: COMPLETED
-
Hyperpolarized 129Xe MRI Lung Health Cohort
NCT05766384 ·Status: RECRUITING
-
Imaging Lung Function Using Oxygen Enhanced MRI
NCT01731015 ·Status: COMPLETED ·Phase: PHASE1
-
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
NCT02748798 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease
NCT03455686 ·Status: RECRUITING ·Phase: NA
-
Study of Inflammatory and Physiological Profiles of Healthy and Diseased Lung
NCT06144476 ·Status: RECRUITING
-
Functional MR Lung Imaging Using Hyperpolarised 129Xe
NCT02976935 ·Status: COMPLETED
-
Functional Applications of Hyperpolarized 129Xe MRI
NCT01697332 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
NCT04624490 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of 133Xe Scintigraphy With 19F MRI
NCT03532334 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
NCT03909477 ·Status: RECRUITING
-
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
NCT01710449 ·Status: COMPLETED ·Phase: PHASE1
-
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
NCT00846573 ·Status: TERMINATED ·Phase: NA
-
Imaging Regional Lung Defect Severity
NCT01640288 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Breath Analysis in Children by New Point-of-care Instruments
NCT03377686 ·Status: COMPLETED
-
Structure and Function MRI of Asthma
NCT02351141 ·Status: RECRUITING ·Phase: NA
-
Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction
NCT00871637 ·Status: COMPLETED
-
Helium-3 MRI Imaging Study in COPD
NCT02207452 ·Status: COMPLETED ·Phase: PHASE1
-
Pulmonary Function Test Study - Automated Interpretation
NCT03264417 ·Status: COMPLETED